Metabolon and Syngenta renew research agreement

Date:12-07-2012

Metabolon, Inc., the pioneering leader in metabolomics-driven biomarker discovery and analysis, announced that it has renewed a multi-year agreement with Syngenta, a world leading global agribusiness. Through this agreement, Metabolon will continue to provide Syngenta broad access to its biochemical profiling technology for use in agricultural applications. Financial terms of the agreement were not disclosed.

Metabolon has extensive experience in rapidly profiling the biochemistry of plants. This metabolomics-driven approach enables the identification of biomarkers useful for the development of a wide range of diagnostics and provides insight into complex biochemical processes.
 
"We are delighted to continue our partnership with Syngenta, a leader in seed biotechnology and crop protection products,” said John Ryals, Ph.D., President and Chief Executive Officer of Metabolon. “This agreement signifies not only the value our biochemical analysis and expertise brings to our collaborators, but also our commitment to helping our partners in pharmaceutical, biotechnology and consumer products sectors meet their own business objectives.”
 
"Metabolon brings us key information that helps facilitate decision-making in R&D for developing new products,” said Michiel van Lookeren Campagne, Head of Biotechnology at Syngenta. “As Syngenta works to bring new technology to the market for our customers, these insights are increasingly important.”